| Ku acts in a unique way at the mammalian telomere to prevent end joining HL Hsu, D Gilley, SA Galande, MP Hande, B Allen, SH Kim, GC Li, ... Genes & development 14 (22), 2807-2812, 2000 | 435 | 2000 |
| Ku is associated with the telomere in mammals HL Hsu, D Gilley, EH Blackburn, DJ Chen Proceedings of the National Academy of Sciences 96 (22), 12454-12458, 1999 | 421 | 1999 |
| MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer YS Weng, HY Tseng, YA Chen, PC Shen, AT Al Haq, LM Chen, YC Tung, ... Molecular cancer 18, 1-15, 2019 | 313 | 2019 |
| Defining interactions between DNA-PK and ligase IV/XRCC4 HL Hsu, SM Yannone, DJ Chen DNA repair 1 (3), 225-235, 2002 | 150 | 2002 |
| Isolation of Ku70-binding proteins (KUBs) CR Yang, S Yeh, K Leskov, E Odegaard, HL Hsu, C Chang, TJ Kinsella, ... Nucleic acids research 27 (10), 2165-2174, 1999 | 134 | 1999 |
| Dynamic changes of NuMA during the cell cycle and possible appearance of a truncated form of NuMA during apoptosis HL Hsu, NH Yeh Journal of cell science 109 (2), 277-288, 1996 | 93 | 1996 |
| Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression LM Chen, PY Liu, YA Chen, HY Tseng, PC Shen, PA Hwang, HL Hsu Scientific Reports 7 (1), 11864, 2017 | 45 | 2017 |
| Expression of the candidate MCT-1 oncogene in B-and T-cell lymphoid malignancies B Shi, HL Hsu, AM Evens, LI Gordon, RB Gartenhaus Blood 102 (1), 297-302, 2003 | 43 | 2003 |
| The antagonism between MCT-1 and p53 affects the tumorigenic outcomes R Kasiappan, HJ Shih, MH Wu, CO Choy, TD Lin, L Chen, HL Hsu Molecular Cancer 9, 1-17, 2010 | 42 | 2010 |
| The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells HL Hsu, B Shi, RB Gartenhaus Oncogene 24 (31), 4956-4964, 2005 | 38 | 2005 |
| Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity HJ Shih, HH Chen, YA Chen, MH Wu, GG Liou, WW Chang, L Chen, ... Oncotarget 3 (11), 1401, 2012 | 35 | 2012 |
| Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity R Kasiappan, HJ Shih, KL Chu, WT Chen, HP Liu, SF Huang, CO Choy, ... Molecular Cancer Research 7 (4), 536-548, 2009 | 34 | 2009 |
| Interplay between cell migration and neurite outgrowth determines SH2B1β-enhanced neurite regeneration of differentiated PC12 cells CL Wu, YH Chou, YJ Chang, NY Teng, HL Hsu, L Chen PloS one 7 (4), e34999, 2012 | 30 | 2012 |
| MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage HL Hsu, CO Choy, R Kasiappan, HJ Shih, JR Sawyer, CL Shu, KL Chu, ... DNA repair 6 (9), 1319-1332, 2007 | 30 | 2007 |
| Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression HY Tseng, YA Chen, J Jen, PC Shen, LM Chen, TD Lin, YC Wang, ... Oncogenesis 6 (4), e313-e313, 2017 | 28 | 2017 |
| Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice LM Chen, PP Yang, AT Al Haq, PA Hwang, YC Lai, YS Weng, MA Chen, ... Journal of Biomedical Science 29 (1), 70, 2022 | 27 | 2022 |
| Oligo-fucoidan prevents M2 macrophage differentiation and HCT116 tumor progression LM Chen, HY Tseng, YA Chen, AT Al Haq, PA Hwang, HL Hsu Cancers 12 (2), 421, 2020 | 27 | 2020 |
| Apoptotic cleavage of NuMA at the C-terminal end is related to nuclear disruption and death amplification HH Lin, HL Hsu, NH Yeh Journal of biomedical science 14, 681-694, 2007 | 26 | 2007 |
| Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress AT Al Haq, HY Tseng, LM Chen, CC Wang, HL Hsu Cell Death & Disease 13 (1), 49, 2022 | 23 | 2022 |
| MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation MH Wu, YA Chen, HH Chen, KW Chang, IS Chang, LH Wang, HL Hsu Oncogene 33 (43), 5109-5120, 2014 | 23 | 2014 |